» Articles » PMID: 37069199

Health Economic Evaluation of a Randomized Controlled Trial (EMBLA Study), an Internet-based Treatment for Provoked Vulvodynia

Overview
Journal Sci Rep
Specialty Science
Date 2023 Apr 17
PMID 37069199
Authors
Affiliations
Soon will be listed here.
Abstract

Internet-based treatment (IBT) for provoked vulvodynia (PVD) may reduce pain during intercourse and increases pain acceptance. However, a there is still a knowledge gap regarding the cost-effectiveness of IBT for PVD. The aim of this study was to perform a health economic evaluation of guided internet-based intervention for PVD as an addition to standard treatment. The sample consisted of 99 women with a PVD diagnosis. Healthcare related costs, health-related quality of life, and quality-adjusted life-years (QALYs) and incremental cost-effectiveness ratio (ICER) were analyzed. After the IBT, the intervention group had fewer visits to a midwife than the control group (p = 0.03), but no between-group differences were found for visits to other professionals, treatment length, health-related quality of life, QALYs, and costs for treatment. It was estimated a cost of 260.77 € for a clinical meaningful change in pain acceptance. Internet-based treatment as add-on to clinical treatment may lower number of visits to a healthcare.

References
1.
Bond J, Harlow B, White K . Care Seeking for Chronic Vulvar Pain Among a Large, Population-Based Sample of Reproductive-Aged Women. J Womens Health (Larchmt). 2021; 31(4):513-520. PMC: 9063164. DOI: 10.1089/jwh.2021.0086. View

2.
McCracken L, Vowles K, Eccleston C . Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004; 107(1-2):159-66. DOI: 10.1016/j.pain.2003.10.012. View

3.
Hess Engstrom A, Bohm-Starke N, Kullinger M, Hogberg U, Buhrman M, Skalkidou A . Experiences of internet-based treatment for vulvodynia: A qualitative study. Sex Reprod Healthc. 2022; 33:100756. DOI: 10.1016/j.srhc.2022.100756. View

4.
Herbert M, Dochat C, Wooldridge J, Materna K, Blanco B, Tynan M . Technology-supported Acceptance and Commitment Therapy for chronic health conditions: A systematic review and meta-analysis. Behav Res Ther. 2021; 148:103995. PMC: 8712459. DOI: 10.1016/j.brat.2021.103995. View

5.
Janssen M, Pickard A, Golicki D, Gudex C, Niewada M, Scalone L . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2012; 22(7):1717-27. PMC: 3764313. DOI: 10.1007/s11136-012-0322-4. View